Detalhe da pesquisa
1.
Clinical characteristics of complete responders versus non-complete responders to omalizumab, benralizumab and mepolizumab in patients with severe asthma: a long-term retrospective analysis.
Ann Med
; 56(1): 2317356, 2024 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38364218